GPFA
CLRB icon

Game Plan Financial Advisors’s Cellectar Biosciences CLRB Stock Holding History

Game Plan Financial Advisors’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-132
Closed -$51K – 56
2020
Q2 		$51K Hold
132
– – 0.07% 54
2020
Q1 		$51K Sell
132
-13
-9% -$8.7K 0.06% 79
2019
Q4 		$98K Buy
+145
New +$75.4K 0.09% 88

Other funds holding CLRB

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $5.7B AUM 21.25% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Game Plan Financial Advisors's CLRB Position: Q3 2020 in Review

Game Plan Financial Advisors sold out of Cellectar Biosciences (CLRB) in Q3 2020, closing a stake of 132 shares — an estimated $51K sold.

Game Plan Financial Advisors first reported a position in CLRB in Q4 2019 and held it in 3 quarters. The position peaked at $98K in Q4 2019. 20 funds tracked by Wall St. Rank hold CLRB as of Q3 2020.

  • Game Plan Financial Advisors reported no remaining Cellectar Biosciences position as of Q3 2020 after selling out during the quarter.
  • Game Plan Financial Advisors sold 132 Cellectar Biosciences shares in Q3 2020, an estimated $51K.
  • Game Plan Financial Advisors first reported a position in Cellectar Biosciences in Q4 2019 and held it in 3 quarters.
  • Game Plan Financial Advisors's Cellectar Biosciences position peaked at $98K in Q4 2019.
  • 20 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2020.

Based on Game Plan Financial Advisors's 13F filing for Q3 2020, filed 9 Nov 2020.